foxo4-dri senolytic peptide human trial inhibitors targeting FOXO4-p53 interactions and inducing senescent cancer cell-specific apoptosis FOXO4-DRI regulates endothelial cell senescence

No states have outright banned non-FDA-approved peptides, but some are cracking down on online sales

Access the full report here: Key Insights: Strengths: First-in-class mechanism, strong efficacy data on proteinuria & eGFR

BPC-157 Standalone Targeted tissue repair and inflammation support A synthetic peptide derived from a naturally occurring protein, BPC-157 promotes angiogenesis, improves blood flow to damaged areas, and supports healing across musculoskeletal and gastrointestinal systems at the cellular level

Ebba Nex is an esteemed expert in the field of B12 with many publications in her name and is Professor emerita at Aarhus University Hospital, Department of Clinical Medicine where she is involved in research in various aspects of mainly biomarkers for B12 status